and GSAS Harvard Biotechnology Club Announces Winners of Biotechnology Business Plan Competition

Winners to Present Plans to Panel of Venture Capitalists at

Biotech Beach 2000 Life Sciences Expo

May 18, 2000, 01:00 ET from

    SAN FRANCISCO, May 18 /PRNewswire/ --, the global hubsite for
 the life sciences industry, and GSAS Harvard Biotechnology Club today
 announced the winners of the first Biotechnology Business Plan
 Competition.  The contest is part of's Biotech Beach 2000 Life
 Sciences Expo, taking place on May 20th in San Diego, California.  Biotech
 Beach 2000 is a full day event that combines forums geared towards
 professionals, entrepreneurs, students and investors in the life sciences
 industry with a career fair that attracts recruiters from over 40 companies.
     The inaugural Business Plan Competition, sponsored by and
 held in association with the Harvard University biotechnology student
 organization, was a nationwide contest open to entrepreneurs with a developed
 plan seeking financing for their early stage, life sciences based business
 concept.  Winners were chosen by a panel organized by the GSAS Harvard
 Biotechnology Club.
     First prize was awarded to Dermamax Technology for their plan to
 commercialize a technology for the transdermal application of medication.  The
 Dermamax team consists of John Abernathy, Joseph Wagner, and Pratush Gupta,
 three MBA students from the University of Georgia.
     Second prize went to NewCo, a proposed spinout from PPL Therapeutics Inc.,
 a leading company in the application of transgenic technology.  NewCo intends
 to develop and commercialize organ xenotransplantation from transgenic pigs.
 The team consists of five PPL Therapeutics Inc. officers, including Dr. Ron
 James, CEO, Dr. David Ayares, VP Research and Development, Paul Rohricht, VP
 Business Development, Dr. Marilyn Moore, Xenotransplantation Program
 Coordinator and Immunologist, and Dr. Alan Colman, Research Director.
     Both the first and second contest prizes consist of $1000 and an expense
 paid trip to San Diego, where the competition culminates with the two chosen
 winners presenting their business plans to a panel of venture capitalists at
 Biotech Beach 2000's Start-Up Forum.  The Start-Up Forum, a new addition to
 the expo, is designed to educate entrepreneurs about the basics of starting a
 life sciences company.  Among the many topics covered by the forum are such
 critical activities for start-up companies as attracting top management and
 raising money from professional investors.  Speakers and panelists include;
 Alan Paau, Director, Tech Transfer & Intellectual Property Services,
 University of California San Diego, Doug Kelly, General Partner, Alloy
 Ventures, Christopher Reinhard, Co-Founder, Pres/COO, Collateral Therapeutics,
 Inc., Brian Atwood, Managing Director, Versant Ventures, Mike Powell, Managing
 Director, Sofinnova Ventures, and Drew Senyei, General Partner, Enterprise
      "The Start-up Forum and the Business Plan Competition are new vehicles
 fueled by our industry's reliance on the entrepreneurial spirit," said Norm
 Wada, Executive Vice President of  "We believe their addition
 greatly enhances the Biotech Beach 2000 expo, and subsequently the benefits we
 bring to the life sciences community through these events."
      In addition to the Start-up Forum, the Industry Forum is the second forum
 being inaugurated at Biotech Beach 2000. Coordinated by the Keck Graduate
 Institute, a pioneering graduate school dedicated to emerging discoveries in
 the biosciences, the Industry Forum will have a panel of top executives on
 hand to discuss a range of topics regarding trends in the life-sciences.
 Speakers include; Joe Panetta, President and CEO, Biocom, David Galas, Chief
 Academic Officer, KGI Systems, Lewis Shuster, COO, Invitrogen.  Panelists and
 moderators include; Miguel Barbosa, Professor, KGI, Don Bobo, Director of
 Business Development, Edwards Life Sciences, Graham Lidgard, VP for R&D,
 Gen-Probe, Mark Brann, Founder, CEO and President, Acadia Pharmaceuticals,
 Marek Liyanage, Senior Scientist, Aurora Biosciences, Stephen McCormack, Dir.
 of Science and Tech Development, Keck Graduate Institute, Dr. Stanley Crooke,
 Founder, Chairman and CEO, Charles Cantor, CSO, Sequenom, Manny Diaz-Conti,
 Director of Finance, Cypress Biosciences, Daniel Bradbury, Sr. VP of Corporate
 Development, Amylin, Jay Knowles, VP of Business Development, Structural
 Genomix, Inc.
     Returning forums, forum members, sponsors, and participating Career Fair
 companies include:
     * Investor Forum -- The forum exposes an audience of retail investors to
 life sciences investment information traditionally reserved for institutional
 investors and industry analysts.  Guest speakers include Faraz Naqvi of
 Dresdner RCM Capital and Jim McCamant, founder and editor of the Medical
 Technology Stock Letter and Agbiotech Stock Letter.  Participating companies
 include; Alliance Pharmaceuticals, Amylin Pharmaceuticals, Aronex
 Pharmaceuticals, Collateral Therapeutics, Corvas, Diversa Corporation,
 Epimmune, Gene Logic, Hollis-Eden Pharmaceutical, NPS Pharmaceutical, Trega
 Biosciences, Vical, and XOMA Corporation.  The forum is sponsored by Informed
 Investors and Incyte Genomics.
     * Career Forum -- The forum covers employment opportunities in the
 industry and a discussion on recent trends regarding reapplication of life
 sciences skills to alternate areas such as marketing, public relations and
 business development.  Guest speakers include; Cynthia Robbins-Roth,
 Editor-in-Chief, BioVentures Publishing, Subhash B. Karkare, Associate
 Director, Manufacturing, Amgen, and Judy Fox, Manager of Employment, Allergan.
 Panel members include: Steve Dahms, Ph.D., San Diego State University, Kate
 Murashige, Partner, Morrison & Foerster LLP, Emmelyn Eldridge, Ph.D., Medical
 Writer, IDEC Pharmaceuticals, and Patrick Hankey, Ph.D., Director of Business
 Development, Clinicor.  The forum is sponsored by Next Wave.
     * Career Fair -- The fair is an offline extension of's
 comprehensive life sciences career listings provided on its website.  This
 year's participating companies include; Aerotek Scientific Staffing, Agilent
 Technologies, Allergan, Alliance Pharmaceuticals, Amgen, Aurora Biosciences,
 Aviron, Axys Pharmaceuticals, Baxter Hyland Immuno, Bioview, Caliper
 Technologies, Cell Genesys, ChemBridge, Chemicon, Inc., Digital Gene
 Technologies, Elan Pharmaceuticals, Exelixis, Inc., Genentech, Gen-Probe
 Inc./Chugai BioPharmaceuticals, Gilead Sciences, Hollis-Eden Pharmaceuticals,
 IDEC Pharmaceuticals, Incyte Genomics, Inhale Therapeutics, Keck Graduate
 Institute, Kelly Scientific Resources, Kforce, Lab Support, Ligand
 Pharmaceuticals, Merck Research Laboratories, Nanogen, PAREXEL, PE Biosystems,
 Pharmacyclics, PharmaNet, Pharmingen/BD, Science,, Selective
 Genetics, Sugen, Trega Biosciences, and Yoh Scientific.
     Complete details regarding the Biotech Beach 2000 Life
 Sciences expo are available at .
     About ( ) is the global hubsite for the
 life sciences industry.  The company has created a point of convergence for
 those who work in the industry by providing Community, Content and Commerce on
 a feature-rich platform. is dedicated to accelerating discovery
 in the life sciences by facilitating exchange crucial to the industry through
 the application of contextual commerce, an end-to-end e-commerce solution. attracts over 2 million page views per month from over
 300,000 unique visitors seeking real-time industry news, information
 resources, investment data, company profiles, stock quotes, employment
 listings, and an innovative business-to-business (B2B) supply solution
 developed cooperatively with the National Institute of Health (NIH).